Search research articles
Contact Us
Filters
Showing results (61-70 of 85) with videos related to
Page
of 9
Sort By:
Biochemical and Biophysical Research Communications
|
April 15, 1991
Vascular A10 cell membranes contain an endothelin metabolizing neutral endopeptidase
K E Dickinson, A A Tymiak, R B Cohen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1993
Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets
M L Webb, E C Liu, H Monshizadegan, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 1991
Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype
C von Bahr, G Movin, C Nordin, et al.
Health Services Research
|
April 13, 1999
Developing quality measures for adolescent care: validity of adolescents' self-reported receipt of preventive services
J D Klein, C A Graff, J S Santelli, et al.
Pediatrics
|
February 7, 2001
Improving adolescent preventive care in community health centers
J D Klein, M J Allan, A B Elster, et al.
Journal of Medicinal Chemistry
|
August 1, 1991
Active conformation of 1,4-dihydropyridine calcium entry blockers. Effect of size of 2-aryl substituent on rotameric equilibria and receptor binding
G Rovnyak, N Andersen, J Gougoutas, et al.
Journal of Medicinal Chemistry
|
February 1, 1991
Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents
K S Atwal, B N Swanson, S E Unger, et al.
Journal of Medicinal Chemistry
|
May 1, 1988
Studies directed toward ascertaining the active conformation of 1,4-dihydropyridine calcium entry blockers
G Rovnyak, N Andersen, J Gougoutas, et al.
Scientific Reports
|
February 21, 2025
Discharge distribution in a multi-outlet spillway with varying adverse conditions
Nils Solheim, Mikael P A Hedberg, Gunnar I J Hellström, et al.
Journal of Medicinal Chemistry
|
September 1, 1991
Interphenylene 7-oxabicyclo[2.2.1]heptane thromboxane A2 antagonists. Semicarbazone omega-chains
R N Misra, B R Brown, W C Han, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 85) with videos related to
Sort By:
Page
of 9
Biochemical and Biophysical Research Communications
|
April 15, 1991
Vascular A10 cell membranes contain an endothelin metabolizing neutral endopeptidase
K E Dickinson, A A Tymiak, R B Cohen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1993
Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets
M L Webb, E C Liu, H Monshizadegan, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 1991
Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype
C von Bahr, G Movin, C Nordin, et al.
Health Services Research
|
April 13, 1999
Developing quality measures for adolescent care: validity of adolescents' self-reported receipt of preventive services
J D Klein, C A Graff, J S Santelli, et al.
Pediatrics
|
February 7, 2001
Improving adolescent preventive care in community health centers
J D Klein, M J Allan, A B Elster, et al.
Journal of Medicinal Chemistry
|
August 1, 1991
Active conformation of 1,4-dihydropyridine calcium entry blockers. Effect of size of 2-aryl substituent on rotameric equilibria and receptor binding
G Rovnyak, N Andersen, J Gougoutas, et al.
Journal of Medicinal Chemistry
|
February 1, 1991
Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents
K S Atwal, B N Swanson, S E Unger, et al.
Journal of Medicinal Chemistry
|
May 1, 1988
Studies directed toward ascertaining the active conformation of 1,4-dihydropyridine calcium entry blockers
G Rovnyak, N Andersen, J Gougoutas, et al.
Scientific Reports
|
February 21, 2025
Discharge distribution in a multi-outlet spillway with varying adverse conditions
Nils Solheim, Mikael P A Hedberg, Gunnar I J Hellström, et al.
Journal of Medicinal Chemistry
|
September 1, 1991
Interphenylene 7-oxabicyclo[2.2.1]heptane thromboxane A2 antagonists. Semicarbazone omega-chains
R N Misra, B R Brown, W C Han, et al.
Page
of 9